Document is current
Any future updates will be listed below
-
Authors
Saehan, Rungfah https://orcid.org/0009-0005-2349-9742
Kaewdech, Apichat https://orcid.org/0000-0002-4058-5977
Sripongpun, Pimsiri https://orcid.org/0000-0003-0007-8214
Chamroonkul, Naichaya https://orcid.org/0000-0002-5753-7939
Piratvisuth, Teerha https://orcid.org/0000-0002-6504-8123
Liangpunsakul, Suthat https://orcid.org/0000-0002-5249-9208
Kumwichar, Ponlagrit https://orcid.org/0000-0002-1580-5720
- License Information
-
More Information
Article History
Received: 15 April 2025
Accepted: 18 August 2025
First Online: 21 August 2025
Declarations
:
: Apichat Kaewdech received research grants or support from Roche, Roche Diagnostics, and Abbott Laboratories, and honoraria from Roche, Roche Diagnostics, Abbott Laboratories, and Esai. Dr. Liangpunsakul discloses consulting roles with Durect Corporation, Surrozen, and Korro Bio. However, these roles do not present any conflict of interest concerning the content of this work. Teerha Piratvisuth received research grants from Gilead Sciences, Roche Diagnostics, Janssen, Fibrogen, and VIR and honoraria from Bristol-Myers Squibb, Gilead Sciences, Bayer, Abbott, Esai, Mylan, Ferring, and MSD. The other authors have no relevant conflict of interest to declare.
: This study was exempt from the Ethics committee in accordance with the ethical guidelines of the 1975 Declaration of Helsinki and approved by the Human Research Ethics Unit (HREU) of the Faculty of Medicine, Prince of Songkla University (REC number: REC.66-514-14-1). Due to the retrospective nature of the study, HREU waived the need of obtaining informed consent.
